Literature DB >> 29265404

Randomized clinical trial of duct-to-mucosa versus invagination pancreaticojejunostomy after pancreatoduodenectomy.

Y Senda1, Y Shimizu1, S Natsume1, S Ito1, K Komori1, T Abe1, K Matsuo2, T Sano3.   

Abstract

BACKGROUND: The postoperative pancreatic fistula (POPF) rate for duct-to-mucosa and invagination anastomosis after pancreatoduodenectomy is still debated. The aim of this RCT was to investigate the POPF rate for duct-to-mucosa versus invagination pancreaticojejunostomy.
METHODS: Patients were stratified by pancreatic texture and diameter of the main pancreatic duct and randomized to the duct-to-mucosa or invagination group. The primary endpoint was the rate of clinically relevant POPF (defined as grade B or C). Secondary endpoints were suture material cost for pancreaticojejunostomy, drain insertion duration and duration of postoperative hospital stay.
RESULTS: Some 120 patients undergoing pancreatoduodenectomy were included following consent. Clinically relevant POPF developed in six of 59 patients (10 per cent) in the invagination group and in 14 of 61 patients (23 per cent) in the duct-to-mucosa group (P = 0·077). Duration of drain insertion (6 versus 7 days respectively; P = 0·027) and postoperative hospital stay (19 versus 24 days; P = 0·015) were shorter in the invagination group. Subgroup analysis for 61 patients with a soft pancreas revealed a lower rate of clinically relevant POPF in the invagination group (10 per cent versus 42 per cent in the duct-to-mucosa group; P = 0·010). Among 20 patients with a clinically relevant POPF, the six patients in the invagination group had a shorter duration of drain insertion (38·5 days versus 49 days for 14 patients in the duct-to-mucosa group; P = 0·028) and postoperative hospital stay (42 versus 54·5 days respectively; P = 0·028).
CONCLUSION: This study did not demonstrate a superiority of invagination over duct-to-mucosa pancreaticojejunostomy in the risk of POPF. However, in high-risk patients with a soft pancreas, invagination may reduce the risk of clinically relevant POPF compared with duct-to-mucosa. Registration number: UMIN000005890 (http://www.umin.ac.jp).
© 2017 BJS Society Ltd Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2018        PMID: 29265404     DOI: 10.1002/bjs.10727

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  15 in total

1.  Use of Clavien-Dindo classification in evaluating complications following pancreaticoduodenectomy in 1,056 cases: A retrospective analysis from one single institution.

Authors:  Wei-Guo Wang; Shah Ram Babu; Li Wang; Yang Chen; Bo-Le Tian; Hong-Bo He
Journal:  Oncol Lett       Date:  2018-05-24       Impact factor: 2.967

2.  Superior perianastomotic fluid collection in the early postoperative period affects pseudoaneurysm occurrence after pancreaticoduodenectomy.

Authors:  Hiromitsu Maehira; Hiroya Iida; Haruki Mori; Daiki Yasukawa; Takeru Maekawa; Keiji Muramoto; Katsushi Takebayashi; Sachiko Kaida; Toru Miyake; Masaji Tani
Journal:  Langenbecks Arch Surg       Date:  2021-01-03       Impact factor: 3.445

3.  Double purse-string telescoped pancreaticogastrostomy is not superior in preventing pancreatic fistula development in high-risk anastomosis: a 6-year single-center case-control study.

Authors:  Jonathan Garnier; Jacques Ewald; Ugo Marchese; Anais Palen; Djamel Mokart; Gilles Piana; Jean-Robert Delpero; Olivier Turrini
Journal:  Langenbecks Arch Surg       Date:  2021-11-16       Impact factor: 3.445

Review 4.  Duct-to-mucosa versus other types of pancreaticojejunostomy for the prevention of postoperative pancreatic fistula following pancreaticoduodenectomy.

Authors:  Hua Hai; Zhuyin Li; Ziwei Zhang; Yao Cheng; Zuojin Liu; Jianping Gong; Yilei Deng
Journal:  Cochrane Database Syst Rev       Date:  2022-03-15

5.  The Effect of Fibrinogen/Thrombin-Coated Collagen Patch (TachoSil®) Application in Pancreaticojejunostomy for Prevention of Pancreatic Fistula After Pancreaticoduodenectomy: A Randomized Clinical Trial.

Authors:  Jaewoo Kwon; Sang Hyun Shin; Sukyung Lee; Guisuk Park; Yejong Park; Seung Jae Lee; Woohyung Lee; Ki Byung Song; Dae Wook Hwang; Song Cheol Kim; Jae Hoon Lee
Journal:  World J Surg       Date:  2019-12       Impact factor: 3.352

6.  Randomized clinical trial of the effect of a fibrin sealant patch on pancreatic fistula formation after pancreatoduodenectomy.

Authors:  M Schindl; R Függer; P Götzinger; F Längle; M Zitt; S Stättner; P Kornprat; K Sahora; D Hlauschek; M Gnant
Journal:  Br J Surg       Date:  2018-04-17       Impact factor: 6.939

Review 7.  Surgical techniques and postoperative management to prevent postoperative pancreatic fistula after pancreatic surgery.

Authors:  Hiromichi Kawaida; Hiroshi Kono; Naohiro Hosomura; Hidetake Amemiya; Jun Itakura; Hideki Fujii; Daisuke Ichikawa
Journal:  World J Gastroenterol       Date:  2019-07-28       Impact factor: 5.742

Review 8.  Postoperative pancreatic fistula: a review of traditional and emerging concepts.

Authors:  Christopher B Nahm; Saxon J Connor; Jaswinder S Samra; Anubhav Mittal
Journal:  Clin Exp Gastroenterol       Date:  2018-03-15

9.  Comparison of clinical outcomes between mesh-reinforced pancreatojejunostomy and pancreatogastrostomy following pancreaticoduodenectomy: a cohort study.

Authors:  Junhai Pan; Xiaolong Ge; Wei Zhou; Xin Zhong; Lihu Gu; Hepan Zhu; Xinlong Li; Weilin Qi; Xianfa Wang
Journal:  World J Surg Oncol       Date:  2018-09-17       Impact factor: 2.754

10.  Selection of pancreaticojejunostomy technique after pancreaticoduodenectomy: duct-to-mucosa anastomosis is not better than invagination anastomosis: A meta-analysis.

Authors:  Yunxiao Lyu; Ting Li; Bin Wang; Yunxiao Cheng; Sicong Zhao
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.